← FDA Drug Approvals (Drugs@FDA)

CONSENSI

NDA · New Drug Application · Sponsor: PURPLE BIOTECH · Approved 2018-05-31

Drug application

FDA Application #

NDA210045

Application type

New Drug Application

Brand name

CONSENSI

Generic name

Amlodipine Besylate

Active ingredients

AMLODIPINE BESYLATE; CELECOXIB

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

PURPLE BIOTECH

First approval

2018-05-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown